Alpha Teknova, Inc.

teknova.com

What Do They Do?

Sells media plates, culture media, and molecular biology reagents to pharmaceutical and biotechnology companies, diagnostic businesses, and academic and government research institutions.

How Do They Make Money?

Lab Essentials brings in money from catalog and custom research products, generally counted when shipped. Clinical Solutions sells custom and catalog products for therapies, vaccines, and diagnostic kits; most sales are counted when shipped.

revenue

Segment	Share	How money arrives
Lab Essentials Sold outright	77% FY2022: 77%	Sold outright
Clinical Solutions Sold outright	19% FY2022: 20%	Sold outright
Other	4.5% FY2022: 2.9%

Who Are Their Customers?

Most sales go directly to customers; some orders are handled through distributors.

Do Revenues Turn Into Profits?

No. It lost $17.3M in FY2025.

Operating income, FY2025

−42% of revenue

▼ −35% (Loss) vs FY2024 (−$26.1M, −69%)

Net income, FY2025

−43% of revenue

▼ −35% (Loss) vs FY2024 (−$26.7M, −71%)

Free cash flow, FY2025

−24% of revenue

▼ −28% (Loss) vs FY2024 (−$13.5M, −36%)

How Are They Changing?

Since the FY2025 annual report

Latest quarter: Q2 FY2026, the three months to Jun 30, 2026

Revenue: ▲ +18%; vs $10.3M in Q2 FY2025
Net income: ▼ −11% (Loss); vs −$3.6M in Q2 FY2025

Lab Essentials share of revenue vs 75.8% in Q2 FY2025

Aug 5, 2026 Raises 2026 revenue guidance Now expects $45 million to $47 million in revenue and less than $8 million in free cash outflow for 2026.

Growing. Revenue grew 10% in 4 years, from $36.9M in FY2021 to $40.5M in FY2025, about 2% a year.

Revenue over time

Lab Essentials Clinical Solutions Other Sample Transport

$50M$25M$0

FY2021 FY2022 FY2023 FY2024 FY2025

Who Do They Compete With?

Competes with Thermo Fisher, Millipore, Merck KGaA, Cytiva, Danaher, Hardy Diagnostics, GeminiBio, Boston BioProducts, and Biologos

Comments